ImmunoPrecise Antibodies Ltd.
IPA
$3.20
$0.5721.67%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -13.51% | 251.86% | -10.47% | 12.56% | -45.73% |
| Total Receivables | 3.47% | -11.67% | 49.46% | -21.91% | -2.55% |
| Inventory | 14.28% | -8.03% | 6.61% | -13.06% | -17.76% |
| Prepaid Expenses | 19.40% | -39.38% | -4.62% | 21.55% | -25.63% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -5.30% | 59.74% | 12.47% | -4.56% | -25.73% |
|
|
|||||
| Total Current Assets | -5.30% | 59.74% | 12.47% | -4.56% | -25.73% |
| Net Property, Plant & Equipment | 8.48% | -8.18% | -3.76% | -2.04% | -1.79% |
| Long-term Investments | 9.52% | -4.30% | 0.04% | 1.57% | -59.91% |
| Goodwill | 9.52% | -4.30% | 0.04% | 1.57% | -59.91% |
| Total Other Intangibles | -0.57% | -95.30% | -2.64% | -1.06% | -17.64% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 13.80% | -3.55% | 0.00% | 1.45% | -5.36% |
| Total Assets | 2.23% | -26.89% | 0.24% | -1.64% | -25.79% |
|
|
|||||
| Total Accounts Payable | 122.14% | -33.06% | -21.35% | 10.35% | 24.06% |
| Total Accrued Expenses | -73.81% | 1.63% | 494.71% | -65.00% | -48.11% |
| Short-term Debt | -- | -- | 17.97% | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 14.72% | -2.10% | 2.59% | 2.17% | -13.95% |
| Total Finance Division Other Current Liabilities | -48.45% | 20.90% | 4.61% | 30.94% | -36.86% |
| Total Other Current Liabilities | -48.45% | 20.90% | 4.61% | 30.94% | -36.86% |
| Total Current Liabilities | 5.67% | -30.69% | 10.09% | 36.84% | -12.95% |
|
|
|||||
| Total Current Liabilities | 5.67% | -30.69% | 10.09% | 36.84% | -12.95% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | 17.97% | -- | -- |
| Capital Leases | 7.67% | -7.27% | -2.76% | -2.32% | -6.55% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 10.04% | -92.86% | -5.81% | -17.43% | -44.70% |
| Total Liabilities | 6.82% | -27.98% | 2.28% | 8.24% | -18.03% |
|
|
|||||
| Common Stock & APIC | 4.79% | 6.34% | 0.77% | -0.01% | -1.42% |
| Retained Earnings | -6.53% | -16.00% | -1.59% | -3.54% | -16.69% |
| Treasury Stock & Other | 28.37% | -8.69% | 5.61% | 24.41% | 31.37% |
| Total Common Equity | -1.51% | -25.97% | -1.41% | -8.38% | -30.29% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.51% | -25.97% | -1.41% | -8.38% | -30.29% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.51% | -25.97% | -1.41% | -8.38% | -30.29% |
|
|
|||||